TransAtlantic Capital Inc.(TACI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TACI TransAtlantic Capital Inc.

Market Closed 12-12 16:00:00 EST Delay

{"stockData":{"symbol":"TACI","market":"US","secType":"STK","nameCN":"TransAtlantic Capital Inc.","latestPrice":0.0003,"timestamp":1765573200000,"preClose":0.0003,"halted":0,"volume":0,"delay":15,"floatShares":125000000,"shares":145000000,"eps":-0.000677,"marketStatus":"Market Closed","change":0,"latestTime":"12-12 16:00:00 EST Delay","open":0.0003,"high":0.0003,"low":0.0003,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.000677,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0003,"volumeRatio":0.2331219628928955},"requestUrl":"/m/hq/s/TACI","defaultTab":"news","newsList":[{"id":"2577616183","title":"Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2577616183","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577616183?lang=en_us&edition=fundamental","pubTime":"2025-10-22 20:00","pubTimestamp":1761134400,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., Oct.  22, 2025  (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/22/3171023/0/en/Vera-Therapeutics-to-Host-an-Investor-Call-and-Webcast-to-Provide-an-ORIGIN-3-Update-on-November-6-2025-at-4-30-pm-ET.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TACI","LU1732799900.SGD","LU0726765562.USD","IE0004445015.USD","LU1074936037.SGD","LU1244550221.USD","LU1732800096.USD","IE00BFSS8Q28.SGD","VERA","FSGS","LU0795875086.SGD","IE00B7KXQ091.USD","BK4534","ET","LU1585245621.USD","LU1718418525.SGD","LU2133065610.SGD","BK4610","BK4585","BK4566","BK4588","BK4561","IE00BJTD4V19.USD","BK4209","HST","IE00BFSS7M15.SGD","LU2279689827.SGD","LU1035773651.USD","BK4218","IE00BJJMRX11.SGD","LU0868494708.USD","LU2347655156.SGD","LU2347655073.USD","LU1430594728.SGD","BK4581","LU0795875169.SGD","LU0417517546.SGD","LU1244550494.USD","BK4550","BK4539","LU0256863811.USD","IE00BJJMRY28.SGD","LU0868494617.USD","LU0912757837.SGD","IE00BJTD4N35.SGD","LU0942090050.USD","MCD","BK4144","LU1069347547.HKD","BK4181"],"gpt_icon":0},{"id":"2576272059","title":"Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576272059","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576272059?lang=en_us&edition=fundamental","pubTime":"2025-10-17 21:12","pubTimestamp":1760706720,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., Oct.  17, 2025  (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/17/3168657/0/en/Vera-Therapeutics-Announces-ORIGIN-3-Late-Breaking-Abstract-Selected-as-Featured-Oral-Presentation-at-Opening-Plenary-Session-of-ASN-Kidney-Week-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7KXQ091.USD","BK4581","IE00BJTD4V19.USD","LU1074936037.SGD","LU1585245621.USD","BK4610","LU1244550577.SGD","LU1244550494.USD","LU1732799900.SGD","LU0868494708.USD","LU0417517546.SGD","LU2133065610.SGD","BK4504","LU1244550221.USD","IE00BFSS8Q28.SGD","LU1732800096.USD","LU2279689827.SGD","IE00BJJMRX11.SGD","IE00BFSS7M15.SGD","LU2347655156.SGD","BK4566","BK4550","LU0942090050.USD","BK4139","LU0726765562.USD","BK4539","LU2347655073.USD","BK4209","LU0795875169.SGD","FSGS","IE0004445015.USD","IE00BJTD4N35.SGD","IE00BJJMRY28.SGD","LU0256863811.USD","LU1069347547.HKD","LU1430594728.SGD","MCD","BK4588","LU0795875086.SGD","BK4585","LU1718418525.SGD","BK4534","LU0912757837.SGD","LU1035773651.USD","VERA","TACI","LU0868494617.USD"],"gpt_icon":0},{"id":"2569208685","title":"First-in-Class Potential! FDA Clears IND Application for LBL-047, an Anti-BDCA2/TACI Bispecific Fusion Protein Developed by Leads Biolabs","url":"https://stock-news.laohu8.com/highlight/detail?id=2569208685","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569208685?lang=en_us&edition=fundamental","pubTime":"2025-09-22 12:29","pubTimestamp":1758515340,"startTime":"0","endTime":"0","summary":"NANJING, China, Sept. 22, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd.  announced that the U.S. Food and Drug Administration  has approved its first-in-human Investigational New Drug  application for LBL-047 on September 19, 2025.LBL-047 is a bispecific fusion protein composed of a humanized anti-blood dendritic cell antigen 2  antibody and an engineered transmembrane activator and CAML interactor  ectodomain independently developed by Leads Biolabs. There are currently no approved clinical trials of drugs targeting both BDCA2 and TACI worldwide. With this unique mechanism of action, LBL-047 holds strong first-in-class potential.By targeting both BDCA2 and BAFF/APRIL, LBL-047 is designed to simultaneously inhibit pDC activity and B-cell maturation, providing a synergistic approach to treating autoimmune diseases such as systemic lupus erythematosus, dermatomyositis, IgA nephropathy and Sjgren's syndrome. LBL-047 is further optimized with glycosylation modifications to enhance a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/first-in-class-potential-fda-clears-ind-application-for-lbl-047-an-anti-bdca2taci-bispecific-fusion-protein-developed-by-leads-biolabs-302562543.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TACI","IND.AU","BK7095"],"gpt_icon":0},{"id":"2533803576","title":"Press Release: Vera Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533803576","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533803576?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532800,"startTime":"0","endTime":"0","summary":"-- On track to announce the primary endpoint results from the atacicept. pivotal Phase 3 ORIGIN trial in IgA Nephropathy  in 2Q 2025;planning for Biologics License Application  submission for atacicept. -- Expanded atacicept development program across multiple autoimmune kidney. \"We are rapidly approaching a significant Vera milestone with the upcoming primary endpoint results from the pivotal atacicept ORIGIN 3 trial, and if successful, we expect this to enable a BLA submission to the FDA in the second half of this year, which may allow approval and commercial launch in 2026. If approved, we believe that atacicept has the potential to advance the standard of care in IgA nephropathy,\" said Marshall Fordyce, M.D., Founder and CEO of Vera Therapeutics. \"The Vera team is well-positioned to build on the success of the lead atacicept development program in IgAN, with the expansion into additional potential indications in other autoimmune kidney diseases and beyond.\". -- Plan to submit a Bio","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732800096.USD","LU2133065610.SGD","BK4209","PMN","LU0912757837.SGD","BK4550","LU1244550221.USD","LU1244550577.SGD","TACI","BKV","LU0256863811.USD","BK4588","LU1430594728.SGD","IE0004445015.USD","IE00BJJMRX11.SGD","BK4139","LU2279689827.SGD","IE00BFSS8Q28.SGD","LU0868494617.USD","LU2347655156.SGD","FSGS","BK4585","LU0795875086.SGD","IE00BJJMRY28.SGD","LU0795875169.SGD","LU1585245621.USD","BK4539","IE00BFSS7M15.SGD","BK4581","BK4566","IE00BJTD4N35.SGD","VERA","BK4007","LU1244550494.USD","BK4610","LU0417517546.SGD","LU1732799900.SGD","LENZ","LU1718418525.SGD","IE00B7KXQ091.USD","IE00BJTD4V19.USD","LU0868494708.USD","LU0942090050.USD","BK4213","BK4504","BK4534"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.transcapinc.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.8002},{"period":"3month","weight":-0.7163},{"period":"6month","weight":-0.8667},{"period":"1year","weight":-0.8667},{"period":"ytd","weight":-0.8333}],"description":"Transatlantic Capital Inc. does not have significant operations. It intends to identify opportunities in commercial properties in the retail, office, and industrial sectors throughout the United States and Canada. The company was formerly known as ACRO Inc. and changed its name to Transatlantic Capital Inc. in May 2014. Transatlantic Capital Inc. was founded in 2002 and is based in Vallejo, California.TransAtlantic Capital Inc. operates as a subsidiary of NFA Securitiers L3C.","exchange":"EXPERT","name":"TransAtlantic Capital Inc.","nameEN":"TransAtlantic Capital Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransAtlantic Capital Inc.(TACI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TransAtlantic Capital Inc.(TACI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TransAtlantic Capital Inc.,TACI,TransAtlantic Capital Inc.股票,TransAtlantic Capital Inc.股票老虎,TransAtlantic Capital Inc.股票老虎国际,TransAtlantic Capital Inc.行情,TransAtlantic Capital Inc.股票行情,TransAtlantic Capital Inc.股价,TransAtlantic Capital Inc.股市,TransAtlantic Capital Inc.股票价格,TransAtlantic Capital Inc.股票交易,TransAtlantic Capital Inc.股票购买,TransAtlantic Capital Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransAtlantic Capital Inc.(TACI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TransAtlantic Capital Inc.(TACI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction